Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01665703 · ClinicalTrials.gov registry record · NA
Imaging Correlates of Renal Cell Carcinoma Biological Features
A NA study, sponsored by UNC Lineberger Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 17
- Enrollment target
NCT01665703 is a NA study that has completed, run by UNC Lineberger Comprehensive Cancer Center. The registered enrollment target is 17 participants.
The verdict
NCT01665703, a NA study, has completed, sponsored by UNC Lineberger Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
Study Summary
This pilot study is designed to evaluate imaging parameters indicative of underlying tumor biology. Patients with large renal masses (\>3 cm, or at the discretion of the investigator) who are planning to undergo nephrectomy will be identified, and recruited to undergo a contrast-enhanced magnetic resonance-Fluorodeoxyglucose-positron emission tomography (MR-FDG-PET) scan.
Interventions
- PROCEDURE FDG PET/MR
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2012-08 |
| Est. Completion | 2019-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01665703
The ClinicalTrials.gov registry entry for NCT01665703 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is UNC Lineberger Comprehensive Cancer Center, which has 366 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which FDG PET/MR is the first listed.
NCT01665703 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01665703 about?
NCT01665703 is a clinical study titled "Imaging Correlates of Renal Cell Carcinoma Biological Features". This pilot study is designed to evaluate imaging parameters indicative of underlying tumor biology. Patients with large renal masses (\>3 cm, or at the discretion of the investigator) who are planning to undergo nephrectomy will be identified, and recruited to undergo a contrast-enhanced magnetic re...
What is the current status of trial NCT01665703?
This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2012-08. Estimated completion is 2019-01.
What interventions are being tested in trial NCT01665703?
The interventions under investigation include: FDG PET/MR (PROCEDURE).
Who is sponsoring clinical trial NCT01665703?
This trial is sponsored by UNC Lineberger Comprehensive Cancer Center, which has 366 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.